Sign In
Buy IRIX
$1.18
+0 (+0%)
At Close: Jun 23, 2026
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q2 2021 Results - Earnings Call Transcript
11:01pm, Thursday, 12'th Aug 2021
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q2 2021 Results - Earnings Call Transcript
Iridex (IRIX) Reports Q2 Loss, Tops Revenue Estimates
08:04pm, Thursday, 12'th Aug 2021
Iridex (IRIX) delivered earnings and revenue surprises of 43.75% and 15.65%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Iridex: Q2 Earnings Insights
05:30pm, Thursday, 12'th Aug 2021
Shares of Iridex (NASDAQ:IRIX) moved higher by 1.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 145.00% over the past year to $0.09, which
Iridex to Present at the 2021 H.C. Wainwright Ophthalmology Virtual Conference
04:05pm, Monday, 09'th Aug 2021
MOUNTAIN VIEW, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
Iridex: A Clear Vision For Success
03:45pm, Tuesday, 18'th May 2021
IRIX recently blew away analyst estimates for Q1 sales, with multiple tailwinds for continued success in 2021 and beyond.
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q1 2021 Results - Earnings Call Transcript
03:07am, Wednesday, 12'th May 2021
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q1 2021 Results - Earnings Call Transcript
Earnings Preview: Iridex (IRIX) Q1 Earnings Expected to Decline
03:47pm, Tuesday, 04'th May 2021
Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Iridex (IRIX) Beats on Q4 Earnings, Revenues Increase Y/Y
01:38pm, Tuesday, 23'rd Mar 2021
Iridex's (IRIX) fourth-quarter 2020 results benefit from strong product line-up and expanding market position.
Iridex Corporation (IRIX) CEO David Bruce on Q4 2020 Results - Earnings Call Transcript
08:04pm, Monday, 22'nd Mar 2021
Iridex Corporation (IRIX) CEO David Bruce on Q4 2020 Results - Earnings Call Transcript
Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates
06:09pm, Monday, 22'nd Mar 2021
Iridex (IRIX) delivered earnings and revenue surprises of 90.91% and 0.40%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Iridex: Q4 Earnings Insights
05:43pm, Monday, 22'nd Mar 2021
Shares of Iridex (NASDAQ:IRIX) decreased 0.4% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 90.91% year over year to ($0.01), which beat
Iridex Announces Fourth Quarter and Full Year 2020 Financial Results
04:08pm, Monday, 22'nd Mar 2021
MOUNTAIN VIEW, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 2, 2021.
Preview: Iridex's Earnings
10:46am, Friday, 19'th Mar 2021
Iridex (NASDAQ:IRIX) releases its next round of earnings this Monday, March 22. Here is Benzinga's essential guide to Iridex's Q4 earnings report.
Iridex (IRIX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:14pm, Monday, 15'th Mar 2021
Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Iridex Completes Transaction with Topcon Corporation
04:05pm, Wednesday, 10'th Mar 2021
MOUNTAIN VIEW, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal
